133 related articles for article (PubMed ID: 3350355)
1. Twice-daily radiation therapy for head and neck carcinomas.
Wang CC
Front Radiat Ther Oncol; 1988; 22():93-8. PubMed ID: 3350355
[No Abstract] [Full Text] [Related]
2. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
[No Abstract] [Full Text] [Related]
3. Concomitant chemoradiation for head and neck cancer: saving lives or grays?
Henk JM
Clin Oncol (R Coll Radiol); 2001; 13(5):333-5. PubMed ID: 11716224
[No Abstract] [Full Text] [Related]
4. [Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
Horiot JC; Bontemps P; Begg AC; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M
Bull Cancer Radiother; 1996; 83(4):314-20. PubMed ID: 9081333
[No Abstract] [Full Text] [Related]
5. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Head Neck; 1993; 15(2):87-96. PubMed ID: 8440619
[TBL] [Abstract][Full Text] [Related]
6. Need for objective patient selection criteria for palliative radiotherapy in advanced head and neck cancer.
Chilukuri S; Laskar SG; Murthy V; Agarwal JP; Budrukkar A; Dinshaw KA
Radiother Oncol; 2008 May; 87(2):308; author reply 309. PubMed ID: 18417233
[No Abstract] [Full Text] [Related]
7. Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma.
Horiot JC; Begg AC; Le Fur R; Schraub S; van den Bogaert W; van Glabbeke M; Pierart M
Recent Results Cancer Res; 1994; 134():111-9. PubMed ID: 8153427
[No Abstract] [Full Text] [Related]
8. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
9. Postoperative irradiation for squamous cell carcinomas of the head and neck: analysis of time-dose factors related to control above the clavicles.
Marcus RB; Million RR; Cassissi NJ
Int J Radiat Oncol Biol Phys; 1979; 5(11-12):1943-9. PubMed ID: 544572
[No Abstract] [Full Text] [Related]
10. Dose escalation, treatment protraction, and the steepness of the dose-response curve for squamous cell carcinoma of the head and neck.
Yaes RJ
Radiother Oncol; 1995 Jan; 34(1):81-3. PubMed ID: 7792405
[No Abstract] [Full Text] [Related]
11. [Value of SPECT-immunoscintigraphy in radiation treatment planning for patients with squamous cell carcinomas in the head and neck area].
Adamietz IA; Schemmann F; Baum RP; Knecht R; Saran F; Mose S; Thilmann C; Hör G; Böttcher HD
Strahlenther Onkol; 1995 May; 171(5):278-83. PubMed ID: 7770783
[TBL] [Abstract][Full Text] [Related]
12. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases.
Bernier J; Bataini JP
Radiother Oncol; 1986 Jun; 6(2):87-103. PubMed ID: 3526423
[TBL] [Abstract][Full Text] [Related]
13. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.
De Crevoisier R; Bourhis J; Eschwège F
Cancer Treat Res; 2003; 114():199-212. PubMed ID: 12619542
[No Abstract] [Full Text] [Related]
14. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab plus radiotherapy for head and neck cancer.
Ho AC
N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16707760
[No Abstract] [Full Text] [Related]
16. Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited.
Bentzen SM; Thames HD
Radiother Oncol; 1992 Oct; 25(2):143-4. PubMed ID: 1438934
[No Abstract] [Full Text] [Related]
17. No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours.
Dubben HH
Radiother Oncol; 1992 Oct; 25(2):142-3. PubMed ID: 1438933
[No Abstract] [Full Text] [Related]
18. Oxygen distributions partly explain the radiation response of human squamous cell carcinomas.
Okunieff P; de Bie J; Dunphy EP; Terris DJ; Höckel M
Br J Cancer Suppl; 1996 Jul; 27():S185-90. PubMed ID: 8763877
[TBL] [Abstract][Full Text] [Related]
19. [Radiotherapy of periodical fraction with massive dose for secondary squamous cell carcinomas of the neck].
Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1970 Jan; 29(10):1253-65. PubMed ID: 5266099
[No Abstract] [Full Text] [Related]
20. Analysis of radiation-induced cell death in head and neck squamous cell carcinoma and rat liver maintained in microfluidic devices.
Carr SD; Green VL; Stafford ND; Greenman J
Otolaryngol Head Neck Surg; 2014 Jan; 150(1):73-80. PubMed ID: 24098006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
